The Implications of the Generics UK ‘Pay-for-Delay’ Ruling of the Court of Justice of the European Union. (C-307/18 Generics UK Ltd and Others v Competition and Market Authority of the 30th January 2020.)

Research output: Contribution to journalArticlepeer-review

5 Downloads (Pure)

Abstract

On 20 January 2020, the Court of Justice of the European Union (CJEU) handed down its ruling in Case C-307/18 Generics (UK) and Others on ten complex questions referred by the UK Competition Appeal Tribunal (CAT) in the context of an appeal against a decision of the UK Competition and Markets Authority (CMA). In what will probably come to be regarded as a landmark judgment in EU competition law, the CJEU ruled for the first time on settlement agreements between originator pharmaceutical companies and producers of generic medicines
Original languageEnglish
Pages (from-to)150-163
Number of pages14
JournalEuropean Competition and Regulatory Law Review
Volume4
Issue number2
Early online date31 May 2020
DOIs
Publication statusPublished - 2020

Keywords

  • European Union
  • EU Competition Law

Fingerprint Dive into the research topics of 'The Implications of the Generics UK ‘Pay-for-Delay’ Ruling of the Court of Justice of the European Union. (C-307/18 Generics UK Ltd and Others v Competition and Market Authority of the 30th January 2020.)'. Together they form a unique fingerprint.

Cite this